Sigma Planning Corp’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Sigma Planning Corp’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-19,480	Closed	-$133K	–	1357
2022 Q2	$133K	Buy	19,480 +4,765	+32%	+$36.5K	﹤0.01%	1200
2022 Q1	$117K	Sell	14,715 -100	-0.7%	-$635	﹤0.01%	1295
2021 Q4	$83K	Sell	14,815 -7,050	-32%	-$52.9K	﹤0.01%	1333
2021 Q3	$168K	Buy	21,865 +550	+3%	+$5.02K	0.01%	1284
2021 Q2	$219K	Sell	21,315 -60	-0.3%	-$610	0.01%	1245
2021 Q1	$225K	Buy	21,375 +9,925	+87%	+$135K	0.01%	1144
2020 Q4	$159K	Buy	+11,450	New	+$159K	0.01%	1137

Other funds holding PNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Sigma Planning Corp's PNT Position: Q3 2022 in Review

Sigma Planning Corp sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q3 2022, closing a stake of 19,480 shares — an estimated $133K sold.

Sigma Planning Corp first reported a position in PNT in Q4 2020 and held it in 7 quarters. The position peaked at $225K in Q1 2021. 106 funds tracked by Wall St. Rank hold PNT as of Q3 2022.

Sigma Planning Corp reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Sigma Planning Corp sold 19,480 POINT Biopharma Global Inc. Common Stock shares in Q3 2022, an estimated $133K.
Sigma Planning Corp first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Sigma Planning Corp's POINT Biopharma Global Inc. Common Stock position peaked at $225K in Q1 2021.
106 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2022.

Based on Sigma Planning Corp's 13F filing for Q3 2022, filed 10 Nov 2022.